Literature DB >> 2898220

A comparison of the antinociceptive and behavioral effects of intrathecally administered opiates, alpha-2-adrenergic agonists, and local anesthetics in mice and rats.

M H Ossipov1, L J Suarez, T C Spaulding.   

Abstract

This study was undertaken to compare the antinociceptive and behavioral effects of intrathecally administered opiates, alpha-2-adrenergic agonists, and local anesthetics injected by lumbar puncture in the mouse and rat. Antinociception was determined by observing the response to a clamp applied to the tail (Haffner test) of the mouse and by the rat tail-flick test; log dose-response curves for antinociception were generated for each drug in each test. Motor coordination and other behavioral effects were also observed. Morphine and fentanyl (mu-opiate agonists) as well as ethylketocyclazocine (EKC) and U50488H (kappa-opiate agonists), together with buprenorphine (partial mu-opiate agonist) and the alpha-2-adrenergic agonist clonidine, all produced antinociception in both species without causing significant behavioral or motor dysfunctions at antinociceptive doses. Xylazine (also an alpha-2-adrenergic agonist), ketamine, procaine, and lidocaine inhibited responses but only at doses that also produced motor impairment or paralysis. Nalbuphine (mixed opiate agonist-antagonist) was without any effect in both species. These data suggest that the mu- and kappa-opiate agonists and clonidine are the preferred agents for producing antinociception without compromising motor function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898220

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions.

Authors:  K Gyires; Z S Zádori; N Shujaa; M Al-Khrasani; B Pap; M M Mózes; P Mátyus
Journal:  Inflammopharmacology       Date:  2009-06-13       Impact factor: 4.473

2.  alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception.

Authors:  F Sierralta; D Naquira; G Pinardi; H F Miranda
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  The spinal antinociceptive activity of the alpha 2-adrenoceptor agonist, xylazine in sheep.

Authors:  A E Kyles; A E Waterman; A Livingston
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Drug-Induced HSP90 Inhibition Alleviates Pain in Monoarthritic Rats and Alters the Expression of New Putative Pain Players at the DRG.

Authors:  Diana Sofia Marques Nascimento; Catarina Soares Potes; Miguel Luz Soares; António Carlos Ferreira; Marzia Malcangio; José Manuel Castro-Lopes; Fani Lourença Moreira Neto
Journal:  Mol Neurobiol       Date:  2017-05-26       Impact factor: 5.590

5.  Glial activation in the collagenase model of nociception associated with osteoarthritis.

Authors:  Sara Adães; Lígia Almeida; Catarina S Potes; Ana Rita Ferreira; José M Castro-Lopes; Joana Ferreira-Gomes; Fani L Neto
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.